Andrew John Davies

Maurizio Martelli, Luca Ceriani, Giovannino Ciccone, Umberto Ricardi, Iryna Kriachok, Barbara Botto, Monica Balzarotti, Alessandra Tucci, Sara Veronica Usai, Vittorio Ruggero Zilioli, Elsa Pennese, Luca Arcaini, Anna Dabrowska-Iwanicka, Andrés Jm Ferreri, Francesco Merli, Weili Zhao, Luigi Rigacci, Claudia Cellini, David Hodgson, Codruta Ionescu, Carla Minoia, Elisa Lucchini, Michele Spina, Alexander Fosså, Andrea Janikova, Kate Cwynarski, George Mikhaeel, Mats Jerkeman, Alice Di Rocco, Yana Stepanishyna, Umberto Vitolo, Armando Santoro, Alessandro Re, Benedetta Puccini, Jacopo Olivieri, Luigi Petrucci, Sally F Barrington, Bogdan Malkowski, Ur Metser, Annibale Versari, Stephane Chauvie, Jan Walewski, Marek Trneny, Franco Cavalli, Mary Gospodarowicz, Peter W.M. Johnson, Andrew Davies & Emanuele Zucca, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 42(34), JCO2401373

DOI: 10.1200/JCO-24-01373

Type: article

Predicting COVID-19 infection risk in lymphoma by immune monitoring

R. Wijaya, N. Campbell, M. Johnson, B. Stuart, A. Kelly, N. Tipler, A. Coleman, A. Turaj, T. Menne, M. Ahearne, V. Willimott, A. Bowzyk Al-Naeeb, C.P. Fox, G.P. Collins, A. O'Callaghan, A.J. Davies, D. Goldblatt & S.H. Lim, 2023, Hematological Oncology, 41(S2), 606-607

DOI: 10.1002/hon.3164_456

Type: conference

Genomic profiling for clinical decision making in lymphoid neoplasms

Laurence De Leval, Ash A. Alizadeh, P. Leif Bergsagel, Elias Campo, Andrew Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M. Horwitz, Ari M. Melnick, William G. Morice, Ryan D. Morin, Bertrand Nadel, Stefano A. Pileri, Richard Rosenquist, Davide Rossi, Itziar Salaverria, Christian Steidl, Steven P. Treon, Andrew D. Zelenetz, Ranjana H. Advani, Carl E. Allen, Stephen M. Ansell, Wing C. Chan, James R. Cook, Lucy B. Cook, Francesco D’amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew L. Feldman, Falko Fend, Philippe Gaulard, Paolo Ghia, John G. Gribben, Olivier Hermine, Daniel J. Hodson, Eric D. Hsi, Giorgio Inghirami, Elaine S. Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfram Klapper, Won Seog Kim, Rebecca L. King, Young H. Ko, Ann S. Lacasce, Georg Lenz, José I. Martin-subero, Miguel A. Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla-martinez, Scott J. Rodig, Andreas Rosenwald, Gilles A. Salles, Jesus San-miguel, Kerry J. Savage, Laurie H. Sehn, Gianpietro Semenzato, Louis M. Staudt, Steven H. Swerdlow, Constantine S. Tam, Judith Trotman, Julie M. Vose, Oliver Weigert, Wyndham H. Wilson, Jane N. Winter, Catherine J. Wu, Pier L. Zinzani, Emanuele Zucca, Adam Bagg & David W. Scott, 2022, Blood, 140(21), 2193-2227

DOI: 10.1182/blood.2022015854

Type: article

ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trial

Andrew Davies, Sharon Barrans, Cathy Burton, Katy Mercer, Joshua Caddy, Fay Chinnery, Laura Day, Diana Fernando, Kirit Ardeshna, Graham Collins, John Radford, Simon Rule, Andrew Mcmillan, Peter Johnson & Gareth Griffiths, 2022, F1000Research, 9

DOI: 10.12688/f1000research.22318.1

Type: article

Immune responses to SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies

Sean H. Lim, Beth Stuart, Debora Joseph-Pietras, Marina Johnson, Nicola Campbell, Adam Kelly, Danielle Jeffrey, Anna H Turaj, Kate Rolfvondenbaumen, Celine Galloway, Thomas Wynn, Adam R. Coleman, Benjamin Ward, Karen Long, Helen Coleman, Carina Mundy, Andrew T. Bates, Diana Ayres, Robert Lown, Janlyn Falconer, Oliver Brake, James Batchelor, Victoria Willimott, Anna Bowzyk Al-Naeeb, Lisa Robinson, Ann O'Callaghan, Graham P Collins, Tobias Menne, Saul N Faust, Christopher P Fox, Matthew Ahearne, Peter W M Johnson, Andrew J Davies & David Goldblatt, 2022, Nature cancer, 3(5), 552-564

DOI: 10.1038/s43018-022-00364-3

Type: article

A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma

Christopher P. Fox, Ayesha S. Ali, Graham McIlroy, Steffi Thust, Nicolás Martinez-Calle, Aimee E. Jackson, Louise M. Hopkins, Catherine M. Thomas, Shireen Kassam, Josh Wright, Sridhar Chaganti, Jeffery Smith, Ian Chau, Dominic Culligan, Kim M. Linton, Graham P. Collins, Andrés J. M. Ferreri, David Lewis, Andrew J. Davies, Rod Johnson, Dorothee P. Auer & Kate Cwynarski, 2021, Blood Advances, 5(20), 4073-4082

DOI: 10.1182/bloodadvances.2021004779

Type: article

Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma

Jonathan Strefford, Mark Cragg, Andrew Davies, Helen Parker & Matthew Rose-Zerilli, 2021, Blood Advances, 5(15), 2935-2944

DOI: 10.1182/bloodadvances.2020003985

Type: article

Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma

Sean H. Lim, Nicola Campbell, Marina Johnson, Debora Joseph-Pietras, Graham P. Collins, Ann O'Callaghan, Christopher Fox, Matthew Ahearne, Peter W.M. Johnson, David Goldblatt & Andrew J. Davies, 2021, The Lancet Haematology, 8(8), e542-e544

DOI: 10.1016/S2352-3026(21)00199-X

Type: article

Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study

Mehdi Hamadani, Graham P Collins, Paolo F Caimi, Felipe Samaniego, Alexander Spira, Andrew Davies, John Radford, Tobias Menne, Anand Karnad, Jasmine M Zain, Paul Fields, Karin Havenith, Hans G Cruz, Shui He, Joseph Boni, Jay Feingold, Jens Wuerthner & Steven Horwitz, 2021, The Lancet Haematology, 8(6), e433-e445

DOI: 10.1016/S2352-3026(21)00103-4

Type: article

Precision medicine in DLBCL

Andrew J Davies, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(12), 1314-1316

DOI: 10.1200/JCO.20.03531

Type: letterEditorial

Professor Andy Davies

Connect with Andy

Research

Research groups

Research projects

Active projects

Completed projects

Publications